Concepedia

Tracy T. Tang

TT

Statistics

Publications

4

Citations

195

H-Index

4

Active since

2022

Affiliations

Mateon Therapeutics (United States)(Current)

Mirati Therapeutics (United States)

Tracy T. Tang is an author at Mateon Therapeutics (United States) specializing in cell biology, cancer therapeutics, and tumor biology.

ORCID

Top concepts

Publications per year

2022–2024

4

Publications

4

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin et al. · Cancer Research · 2023 · 94 citations · Full text

TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors

A. Cole Edwards, Clint A. Stalnecker, Alexis Jean Morales et al. · Cancer Research · 2023 · 68 citations · Full text

Abstract 5364: The TEAD autopalmitoylation inhibitor VT3989 improves efficacy and increases durability of efficacy of osimertinib in preclinical <i>EGFR</i> mutant tumor models

Tracy T. Tang, Leonard Post · Cancer Research · 2022 · 21 citations

, , +18

Non-vesicular phosphatidylinositol transfer plays critical roles in defining organelle lipid composition

Yeun Ju Kim, Joshua G. Pemberton, Andrea Eisenreichová et al. · The EMBO Journal · 2024 · 12 citations · Full text

Rows per page

1–4 of 4